ARTICLE | Company News
Eli Lilly sales and marketing update
February 16, 2015 8:00 AM UTC
The pharma’s Lilly Oncology unit launched the PACE Continuous Innovation Indicators (CII) tool to measure progress against cancer. CII will initially compare 12 tumor types: breast, colon, endometriu...